Prothena Corporation plc
PRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.34 | -1.12 | 0.09 | -0.21 |
| FCF Yield | -20.19% | -7.07% | -3.83% | 4.21% |
| EV / EBITDA | -1.85 | -6.98 | -16.34 | 22.48 |
| Quality | ||||
| ROIC | -29.25% | -27.32% | -16.99% | 11.40% |
| Gross Margin | 100.00% | -141.40% | 87.49% | 58.98% |
| Cash Conversion Ratio | 1.23 | 0.91 | 0.93 | 1.38 |
| Growth | ||||
| Revenue 3-Year CAGR | 35.85% | -23.06% | 298.32% | 526.93% |
| Free Cash Flow Growth | -9.97% | -25.10% | -218.75% | 214.24% |
| Safety | ||||
| Net Debt / EBITDA | 3.00 | 3.19 | 5.35 | -7.87 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -108.73 | -6,329.54 |
| Cash Conversion Cycle | -791.09 | -21.41 | -504.87 | -16.41 |